Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 20, 2025 08:00 ET | Source: Philikos B.V.

Philikos kondigt de start aan van een klinische fase 1/2-studie met T-Guard® bij patiënten met systemische sclerose

NIJMEGEN, the Netherlands, May 20, 2025 (GLOBE NEWSWIRE) -- Philikos B.V., een Nederlands biotechnologiebedrijf dat op antilichamen gebaseerde therapieën ontwikkelt voor de behandeling van ernstige...
May 20, 2025 08:00 ET | Source: Philikos B.V.

Philikos announces initiation of clinical Phase 1/2 study with T-Guard® in patients with systemic sclerosis

NIJMEGEN, the Netherlands, May 20, 2025 (GLOBE NEWSWIRE) -- Philikos B.V., a Dutch biotechnology company developing antibody-based therapies to treat severe immune disorders, today announced that it...
October 14, 2024 06:46 ET | Source: Research and Markets

Immunology Collaboration and Licensing Agreements Trends Report 2024: Explore 862 Detailed Contract Documents via SEC Submissions - Access Deal Payment Terms and Trigger Clauses

Dublin, Oct. 14, 2024 (GLOBE NEWSWIRE) -- The "Immunology Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Fully revised and updated, the...
May 31, 2024 04:34 ET | Source: Research and Markets

Global Systemic Sclerosis (Scleroderma) Clinical Trials Review 2024: Clinical Trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status

Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "Systemic Sclerosis (Scleroderma) - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The...
May 16, 2024 10:45 ET | Source: Research and Markets

Immunology Collaboration and Licensing Agreements Analysis Report 2024 with Directory of Deals Signed Since 2016 - Company A-Z, Therapy Focus and Technology Type

Dublin, May 16, 2024 (GLOBE NEWSWIRE) -- The "Immunology Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Immunology Collaboration and...
January 30, 2024 20:25 ET | Source: Research and Markets

Global Scleroderma Market Forecasts Promising Growth with Latest Industry Trends by 2027

Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Global Scleroderma Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global scleroderma market is poised for...
September 18, 2023 13:30 ET | Source: PMI

Scleroderma Therapeutics Market is estimated to be US$ 4.3 Billion by 2032; Growing Incidence and Screening Rates of Scleroderma to Fuel-By PMI

Covina, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Scleroderma, also known as systemic sclerosis, is a rare and chronic autoimmune disease that primarily affects the connective tissues in the body. There...
April 10, 2023 03:55 ET | Source: Future Market Insights Global and Consulting Pvt. Ltd.

Autoimmune Disease Testing Market is set to reach revenue of US$ 15.75 Billion, expected to grow at 10% CAGR during 2023 to 2033 period | Future Market Insights, Inc.

NEWARK, Del, April 10, 2023 (GLOBE NEWSWIRE) -- According to FMI estimations, the Autoimmune Disease Testing Market could increase from US$ 6.07 billion in 2023 to US$ 15.75 billion by 2033. The...
July 26, 2022 17:50 ET | Source: Aisa Pharma, Inc.

AISA Pharma Announces Positive Data Safety Monitoring Board Review of First Phase 2 Data of Profervia® to treat Raynaud’s Disease in Scleroderma Patients

BOSTON, July 26, 2022 (GLOBE NEWSWIRE) -- Aisa Pharma, Inc. a privately-funded, clinical-stage biopharmaceutical company, today announced that the Data Safety Monitoring Board (DSMB) for the...
March 30, 2022 08:00 ET | Source: Prometheus Biosciences

Prometheus Biosciences Initiates Third Phase 2 Study of PRA023 for Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD)

- First therapeutic candidate for the treatment of SSc-ILD targeting both key fibrotic and inflammatory pathways - - ATHENA-SSc-ILD Phase 2 topline results expected first-half 2024 - - FDA has...

Next Page keyboard_arrow_right

Latest News and Press Releases

Search Results